NCT07641322尚未招募不适用
Dentin Hypersensitivity: Triple-Blinded, Multicenter Randomized Trial of Three Desensitizing Dentifrices vs Non-Desensitizing Control
Nishtar Medical University0 个研究点目标入组 200 人开始时间: 2026年7月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
The effect of desensitizing agents will be studied on dentin hypersensitivity in orthodontic patients.it is a randomized controlled trial. three experimental groups and one placebo group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Orthodontic patients aged 18-40 years.
- •Presence of mild to moderate dentin hypersensitivity (VAS ≥ 4).
- •Willingness to comply with a 12-week follow-up period.
- •No active periodontal disease or untreated caries.
- •Not pregnant or breastfeeding.
- •No history of allergy to desensitizing agents
排除标准
- •o Patients with systemic conditions affecting oral health (e.g., diabetes, immunocompromised).
- •Patients using medications that affect tooth sensitivity (e.g., anti-inflammatory drugs).
研究者
Fatima Khalid
Dr Fatima Khalid
Nishtar Medical University
相似试验
已完成
4 期
A clinical study for the comparison and evaluation of the role of three different agents in the treatment of dentinal hypersensitivity of teeth among the affected patients.CTRI/2024/05/066921Guru Nanak Institute of Dental Science and Researchri24
尚未招募
不适用
Comparing two treatment protocols in reducing Dentin hypersensitivityCTRI/2024/11/077272Dr Juttu Shirisha40
尚未招募
1/2 期
Comparative evaluation of diode laser and seventh generation dentin bonding agent in the treatment of dentinal hypersensitivityCTRI/2024/05/067589Khushi Patel20
尚未招募
Phase 3 4
Comparing the Clinical Efficiency Of Three Desensitizing Agents In Reducing HypersensitivityCTRI/2025/02/081127Kunkati Mounika30
尚未招募
不适用
A Clinical Study on the Effectiveness of Diode Laser–Assisted Desensitizing Agents for Dentinal HypersensitivityCTRI/2025/08/093643Dr Vaishnavi Chidrawar72